SERPINE1 and cancer: We performed a drug-target prediction analysis using the Genomics of Drug Sensitivity in Cancer (GDSC) database [27] and identified candidate drugs (ZG10, Dasatinib, CGP-082996) for HS6ST2, RPS19, and SERPINE1 in gastric cancer (Figure 4E).